SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

被引：358

作者：

Corbett, Kizzmekia S. ^{[1
]}

Edwards, Darin K. ^{[2
]}

Leist, Sarah R. ^{[3
]}

Abiona, Olubukola M. ^{[1
]}

Boyoglu-Barnum, Seyhan ^{[1
]}

Gillespie, Rebecca A. ^{[1
]}

Himansu, Sunny ^{[2
]}

Schafer, Alexandra ^{[3
]}

Ziwawo, Cynthia T. ^{[1
]}

DiPiazza, Anthony T. ^{[1
]}

Dinnon, Kenneth H. ^{[3
]}

Elbashir, Sayda M. ^{[2
]}

Shaw, Christine A. ^{[2
]}

Woods, Angela ^{[2
]}

Fritch, Ethan J. ^{[4
]}

Martinez, David R. ^{[3
]}

Bock, Kevin W. ^{[5
]}

Minai, Mahnaz ^{[5
]}

Nagata, Bianca M. ^{[5
]}

Hutchinson, Geoffrey B. ^{[1
]}

Wu, Kai ^{[2
]}

Henry, Carole ^{[2
]}

Bahl, Kapil

Garcia-Dominguez, Dario ^{[2
]}

Ma, LingZhi ^{[2
]}

Renzi, Isabella ^{[2
]}

Kong, Wing-Pui ^{[1
]}

Schmidt, Stephen D. ^{[1
]}

Wang, Lingshu ^{[1
]}

Zhang, Yi ^{[1
]}

Phung, Emily ^{[1
,6
]}

Chang, Lauren A. ^{[1
]}

Loomis, Rebecca J. ^{[1
]}

Altaras, Nedim Emil ^{[2
]}

Narayanan, Elisabeth ^{[2
]}

Metkar, Mihir ^{[2
]}

Presnyak, Vlad ^{[2
]}

Liu, Cuiping ^{[1
]}

Louder, Mark K. ^{[1
]}

Shi, Wei ^{[1
]}

Leung, Kwanyee ^{[1
]}

Yang, Eun Sung ^{[1
]}

West, Ande ^{[3
]}

Gully, Kendra L. ^{[3
]}

Stevens, Laura J. ^{[7
]}

Gully, Kendra L. ^{[3
]}

Wang, Nianshuang ^{[8
]}

Wrapp, Daniel ^{[8
]}

Doria-Rose, Nicole A. ^{[1
]}

Stewart-Jones, Guillaume ^{[2
]}

机构：

[1] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[2] Moderna Inc, Cambridge, MA USA

[3] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA

[4] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA

[5] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[6] George Washington Univ, Inst Biomed Sci, Washington, DC USA

[7] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA

[8] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA

[9] NIAID, Biostat Res Branch, Div Clin Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

来源：

NATURE | 2020年 / 586卷 / 7830期

关键词：

MERS-COV; SPIKE; INFLUENZA; IMMUNOGENICITY; PROTECTION; VIRUS; RSV;

D O I：

10.1038/s41586-020-2622-0

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to control the coronavirus disease 2019 (COVID-19) global pandemic. Structural studies have led to the development of mutations that stabilize Betacoronavirus spike proteins in the prefusion state, improving their expression and increasing immunogenicity(1). This principle has been applied to design mRNA-1273, an mRNA vaccine that encodes a SARS-CoV-2 spike protein that is stabilized in the prefusion conformation. Here we show that mRNA-1273 induces potent neutralizing antibody responses to both wild-type (D614) and D614G mutant(2) SARS-CoV-2 as well as CD8(+) T cell responses, and protects against SARS-CoV-2 infection in the lungs and noses of mice without evidence of immunopathology. mRNA-1273 is currently in a phase III trial to evaluate its efficacy.

引用

页码：567 / +

页数：21

共 43 条

[11] Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease
Douglas, Madeline G.
Kocher, Jacob F.
Scobey, Trevor
Baric, Ralph S.
Cockrell, Adam S.
[J]. VIROLOGY, 2018, 517 : 98 - 107
[12] Rapid development of a DNA vaccine for Zika virus
Dowd, Kimberly A.
Ko, Sung-Youl
Morabito, Kaitlyn M.
Yang, Eun Sung
Pelc, Rebecca S.
DeMaso, Christina R.
Castilho, Leda R.
Abbink, Peter
Boyd, Michael
Nityanandam, Ramya
Gordon, David N.
Gallagher, John Robert
Chen, Xuejun
Todd, John-Paul
Tsybovsky, Yaroslav
Harris, Audray
Huang, Yan-Jang S.
Higgs, Stephen
Vanlandingham, Dana L.
Andersen, Hanne
Lewis, Mark G.
De La Barrera, Rafael
Eckels, Kenneth H.
Jarman, Richard G.
Nason, Martha C.
Barouch, Dan H.
Roederer, Mario
Kong, Wing-Pui
Mascola, John R.
Pierson, Theodore C.
Graham, Barney S.
[J]. SCIENCE, 2016, 354 (6309) : 237 - 240
[13] Freeman Brandi, 2020, bioRxiv, DOI 10.1101/2020.04.24.057323
[14] ALTERED REACTIVITY TO MEASLES VIRUS - ATYPICAL MEASLES IN CHILDREN PREVIOUSLY IMMUNIZED WITH INACTIVATED MEASLES VIRUS VACCINES
FULGINITI, VA
ELLER, JJ
DOWNIE, AW
KEMPE, CH
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1967, 202 (12) : 1075 - +
[15] Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors
Gilman, Morgan S. A.
Castellanos, Carlos A.
Chen, Man
Ngwuta, Joan O.
Goodwin, Eileen
Moin, Syed M.
Mas, Vicente
Melero, Jose A.
Wright, Peter F.
Graham, Barney S.
McLellan, Jason S.
Walker, Laura M.
[J]. SCIENCE IMMUNOLOGY, 2016, 1 (06)
[16] Rapid COVID-19 vaccine development
Graham, Barney S.
[J]. SCIENCE, 2020, 368 (6494) : 945 - 946
[17] Prototype pathogen approach for pandemic preparedness: world on fire
Graham, Barney S.
Corbett, Kizzmekia S.
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (07) : 3348 - 3349
[18] Structure-Based Vaccine Antigen Design
Graham, Barney S.
Gilman, Morgan S. A.
McLellan, Jason S.
[J]. ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 91 - 104
[19] Novel Vaccine Technologies Essential Components of an Adequate Response to Emerging Viral Diseases
Graham, Barney S.
Mascola, John R.
Fauci, Anthony S.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (14): : 1431 - 1432
[20] Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic
Graham, Barney S.
Sullivan, Nancy J.
[J]. NATURE IMMUNOLOGY, 2018, 19 (01) : 20 - 28

← 1 2 3 4 5 →